1. The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and Cancer
   , 2017, Cancers CrossRef
2. Influence of XRCC4 expression by breast cancer cells on ipsilateral recurrence after breast-conserving therapy
   Mio Kitagawa et al, 2019, Strahlenther Onkol CrossRef
3. The Extract of Cordyceps Militaris Inhibited the Proliferation of Cisplatin-Resistant A549 Lung Cancer Cells by Downregulation of H-Ras
   Mi-Kyung Jeong et al, 2019, Journal of Medicinal Food CrossRef
4. Expression of Ku86 and Presence of Ku86 Antibody as Biomarkers of Hepatitis B Virus Related Hepatocellular Carcinoma
   Yong Xu et al, 2014, Dig Dis Sci CrossRef
5. Influence of XRCC4 expression in esophageal cancer cells on the response to radiotherapy
   Masakazu Hori et al, 2017, Med Mol Morphol CrossRef
6. Effect of Ku80 on the radiosensitization of cisplatin in the cervical carcinoma cell line HeLa
   Liang Zhuang et al, 2017, Oncol Lett CrossRef
7. Nonhomologous end joining repair pathway molecules as predictive biomarkers for patients with oral squamous cell carcinoma
   JignaS Joshi et al, 2021, J Can Res Ther CrossRef
8. The Usefulness of Machine Learning–Based Evaluation of Clinical and Pretreatment [18F]-FDG-PET/CT Radiomic Features for Predicting Prognosis in Hypopharyngeal Cancer
   Masatoyo Nakajo et al, 2022, Mol Imaging Biol CrossRef
9. DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities
   Dana Jurkovicova et al, 2022, IJMS CrossRef
10. Discovery of UMI-77 as a novel Ku70/80 inhibitor sensitizing cancer cells to DNA damaging agents in vitro and in vivo
    Xuening Chen et al, 2024, European Journal of Pharmacology CrossRef